In Huck v. Trimark Physicians Group, No. 12-0596 (Iowa Ct. App. Apr. 24, 2013), the Iowa Court of Appeals affirmed a summary judgment grant for the defendant generic drug maker, holding that federal law preempts state failure to warn claims against generic drug makers. In doing so, the Iowa Court of Appeals followed the lead of the Fifth Circuit, rather than adopting the contrary view embraced by the Sixth Circuit.